TechGen embarks on second heliborne VTEM survey at Mt Boggola

|

Published 07-JUN-2021 15:46 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

TechGen Metals Limited (ASX:TG1) has commenced the scheduled heliborne Versatile Time Domain Electro-Magnetic (VTEMTM Max) geophysical survey within the company’s Mt Boggola Project in the Ashburton Basin of Western Australia.

The Mt Boggola Project consists of two Exploration Licences (E08/2966 & E08/3269) that cover a combined area of 179 square kilometres.

The VTEMTM Max survey at the Mt Boggola Project will consist of approximately 320 line kilometres of surveying with nominal 200-metre spacings between flight lines.

The airborne survey will cover the northern granted project area (E08/2996) as shown below.

Historic exploration shows high-grade copper, silver, gold

The VTEMTM Max system is the most innovative and successful airborne electromagnetic system to be introduced in more than 30 years.

The proprietary receiver design, using the advantages of modern digital electronics and signal processing, delivers exceptionally low-noise levels.

In tech-talk, when you combine this with a high dipole moment transmitter, the result is unparalleled resolution and depth of investigation in precision electromagnetic measurements.

However, setting aside the upcoming surveying, TechGen has had boots on the ground, and historic drilling, rock chip and soil sampling and exploration completed by the group has identified areas of high-grade copper-silver-gold, as well as outcropping copper mineralisation (malachite) within the project area.

Several areas of anomalism are known and the VTEM-Max survey is being undertaken to identify possible sulphide mineralisation at depth across the project area.

XRD analysis has been undertaken on a single rock chip sample which assayed 48.7% copper and 119 g/t silver.

The results of the XRD analysis have indicated that in addition to the presence of copper oxide minerals, the copper sulphide mineral djurleite is also present within the sample.

To provide context, most copper ore bodies are mined from minerals created by weathering of the primary copper ore mineral chalcopyrite.

Minerals in the enriched zone include chalcocite, bornite, djurleite - by contrast, minerals in the oxidized zones include malachite which as we mentioned was identified in outcropping copper mineralisation.

Multiple survey results could provide share price momentum

Consequently, TechGen has already identified two key markers in its quest for unveiling a copper resource that could also contain traces of precious metals.

The VTEM survey is anticipated to take 4 to 5 days to complete.

Further updates across the company’s highly prospective copper-gold project portfolio in Western Australia are imminent.

The same type of airborne survey being conducted at Mt Boggola was just completed last week at the company's Station Creek Project, and these results will emerge prior to those from Mt Boggola, indicating there are potentially multiple catalysts on the horizon.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X